“‘iTBra’ Could Be the Key to Early Breast Cancer Detection”

Cyrcadia’s technology was recently featured and Columbus, Ohio’s WBNS-TV10, notifying the viewing public of the expansion of our clinical trials at The Ohio State University.  We are pleased to have Dr. William Farrar’s support in this endeavor.  Please have a look. ‘iTBra’ could be the key to early breast cancer detection....

Cyrcadia Health Takes Home Gold 2016 Edison Award for Top Health and Wellness Wearable

Reno, Nev. (PRWEB) April 27, 2016 — Cyrcadia, Inc. was recently awarded the gold level citation for Health and Wellness, Wearable and Sensors category from the prestigious Edison Organization presented last week at the annual gala in New York. The company’s breakthrough technology is designed to enable early breast cancer detection through use of a wearable device, the iTBra.™ The technology measures specific circadian biomarkers, which can be early indicators of breast cancer cell infusion. “Not only did Cyrcadia win, but the company beat hundreds of other innovators and dozens in this category to achieve this designation,” said Jason Starbird, CEO, Aebli Group/ Edison. “One in eight women in the U.S. are diagnosed with breast cancer annually and approximately 500,000 women die worldwide from the disease each year, many due to lack of early detection. The Cyrcadia technology may become a substantial game changer.” Cyrcadia’s wearable, smart phone-enabled iTBra technology, uses a comfortable data collection device placed under a bra to collect from two to twelve hours of breast cell data (dynamic cell chaos). Circadian rhythm-based temperature variances of cell cycles are then measured through a Cyrcadia-patented process to identify abnormalities at the earliest stages of cellular change over time. The results collected from the technology are transferred through a smart device to a global cancer library, where advanced analytical analysis occurs. The results then are communicated back to the patient and physician. “We are honored to be receiving this highly regarded award,” said Rob Royea, president of Cyrcadia. “There are numerous and exciting technologies being developed in the healthcare field, which makes the selection of Cyrcadia as the...

The human element of IoE changing the way breast cancer is detected.

Vatsun Thirapatarapong November 3, 2015 8:47 am In Thailand, breast cancer is the number-one cancer killing women, averaging seven women dying per week. More than 19 million Thai women are now in risk of having breast cancer. Such statistics on the occurrence of breast cancer are terrifying, but incredible strides across all forms of cancer are taking place. In many cases, they come in the form of early detection through ground-breaking technology and the Internet of Everything (IOE) Read more here:...

Cyrcadia, Inc. Collaborates With the Canary Foundation for Early Breast Cancer Research

Reno, Nev. (PRWEB)September 22, 2015 via http://www.prweb.com/releases/2015/09/prweb12974574.htm Cyrcadia Health and the Canary Foundation announced their intention to enter into collaborative research on improved early cancer detection screening through the use of Cyrcadia’s wearable devices. Through funding support from the Canary Foundation, Cyrcadia has established a multi-site trial, beginning at a leading Bay Area cancer hospital with near term expansion to the Stefanie Spielman Comprehensive Breast Foundation at The Ohio State University. This research will involve a 173 patient study focused on early breast cancer health screening. “We are excited that the Canary Foundation has taken an interest in our personalized health screening technology,” said Rob Royea, president of Cyrcadia, Inc.    “The potential of collaboration with the only foundation in the world, which over the past 10 years has focused solely on early cancer detection, is highly prestigious. Working together on early biomarker identification for multiple states of cancer will be of significant benefit to our research. Our ability to correlate our findings with those biomarkers which are early indicators of breast cancer infusion is invaluable and could lead to additional applications for our wearable products.” One in eight women in the U.S. alone are diagnosed with breast cancer annually. Approximately 500,000 die worldwide from the disease each year, many due to lack of early detection. The company’s wearable, smartphone enabled technology, called the iTBraTM, uses a comfortable data collection device placed under a bra to collect from two to 12 hours of breast cell data (dynamic cell chaos). Circadian rhythm-based temperature variances of cell cycles are then measured through a patented process to identify abnormalities at the earliest stages of...